Immediate Impact

58 standout
Sub-graph 1 of 22

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
1 intermediate paper

Works of Kadir Bahar being referenced

Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
2013

Author Peers

Author Last Decade Papers Cites
Kadir Bahar 52 313 93 381 130 39 726
Helena Miranda 8 207 173 260 95 54 782
Elizabeth O’Grady 10 327 61 79 155 35 693
Hannah Woopen 2 114 76 291 162 53 819
David Chen 21 64 23 82 111 37 787
Yuko Nagaoki 15 509 9 367 160 46 728
John Robertson 1 173 81 95 83 53 674
Ying Dai 38 284 5 191 189 34 782
Simone S.M. Ho 4 294 16 145 153 25 772
Chih‐Che Lin 9 323 3 277 146 40 586
Mu‐Zon Wu 21 231 3 204 245 44 788

All Works

Loading papers...

Rankless by CCL
2026